BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Nov 19, 2026; 16(11): 123981
Published online Nov 19, 2026. doi: 10.5498/wjp.123981
Table 2 Baseline characteristics of participants with sleep problems stratified by tertiles of the triglyceride-glucose index combined with a body shape index
Characteristic
TyG-ABSI
P value
T1 (≤ 6.66)
T2 (< 7.34)
T3 (≥ 7.34)
Participant217334421
Age (years)42.45 (39.87-45.03)51.05 (49.13-52.98)56.32 (54.83-57.80)< 0.0001
Gender< 0.0001
Male31.76 (24.00-40.67)50.49 (44.49-56.49)64.37 (57.28-70.87)
Female68.24 (59.33-76.00)49.51 (43.51-55.51)35.63 (29.13-42.72)
Race/ethnicity< 0.0001
Non-Hispanic White67.78 (61.29-73.66)71.86 (66.02-77.04)81.14 (76.12-85.30)
Non-Hispanic Black20.76 (16.08-26.39)11.93 (9.14-15.42)4.87 (3.30-7.12)
Mexican American5.04 (2.85-8.76)4.72 (2.78-7.91)4.67 (2.96-7.32)
Other Hispanic3.49 (1.98-6.06)5.47 (3.59-8.25)4.30 (2.71-6.78)
Other race2.92 (1.27-6.59)6.03 (3.71-9.65)5.02 (3.01-8.26)
Education level0.1148
Under Highschool1.66 (0.67-4.05)6.65 (3.93-11.03)6.78 (4.92-9.27)
Highschool30.67 (23.23-39.28)33.05 (26.69-40.10)36.00 (29.80-42.71)
Above Highschool67.66 (59.09-75.19)60.30 (52.28-67.81)57.21 (50.29-63.87)
Poverty income ratio2.95 (2.71-3.18)2.97 (2.69-3.25)2.82 (2.57-3.08)0.6353
Smoke< 0.0001
Never55.46 (46.85-63.76)45.93 (37.86-54.22)34.44 (27.84-41.69)
Former20.01 (13.87-27.97)24.09 (18.92-30.14)38.22 (32.24-44.58)
Now21.87 (16.56-28.31)28.91 (23.41-35.12)27.30 (22.15-33.14)
Alcohol use0.0017
Never11.77 (7.24-18.58)8.87 (5.15-14.87)10.79 (7.78-14.78)
Former10.59 (6.51-16.77)22.62 (17.49-28.73)26.00 (20.30-32.65)
Mild26.14 (19.63-33.89)31.14 (23.17-40.41)33.38 (27.05-40.38)
Moderate26.38 (18.33-36.40)15.40 (10.62-21.79)11.61 (7.88-16.77)
Heavy18.06 (12.16-25.96)18.28 (13.49-24.29)12.92 (9.08-18.06)
Diastolic blood pressure (mmHg)68.90 (67.17-70.64)70.05 (68.49-71.62)70.73 (69.02-72.45)0.3273
Systolic blood pressure (mmHg)117.80 (115.78-119.82)120.46 (118.16-122.76)126.59 (124.74-128.43)< 0.0001
ALT (U/L)22.39 (20.31-24.47)25.33 (23.46-27.20)31.22 (28.25-34.19)0.0001
AST (U/L)23.96 (21.77-26.14)26.46 (23.22-29.70)28.97 (26.70-31.24)0.0134
Blood urea nitrogen (mg/dL)13.16 (12.32-13.99)13.11 (12.53-13.70)14.96 (14.34-15.58)< 0.0001
Creatinine (mg/dL)0.88 (0.85-0.91)0.91 (0.88-0.95)0.99 (0.94-1.03)0.0002
Bilirubin, total (mg/dL)0.73 (0.67-0.79)0.72 (0.68-0.76)0.73 (0.68-0.77)0.9687
Cholesterol, total (mg/dL)181.50 (174.02-188.98)194.00 (188.25-199.75)195.96 (189.73-202.20)0.0222
Direct HDL-cholesterol (mg/dL)59.62 (56.80-62.45)53.43 (51.24-55.63)43.80 (42.29-45.32)< 0.0001
LDH (U/L)129.37 (124.38-134.37)132.71 (128.40-137.03)132.43 (128.78-136.08)0.5165
Triglycerides (mg/dL)73.57 (66.58-80.55)114.43 (107.92-120.94)226.72 (190.74-262.69)< 0.0001
Diabetes mellitus< 0.0001
No83.02 (77.27-87.55)63.15 (57.00-68.90)34.35 (28.13-41.17)
Diabetes mellitus9.42 (6.15-14.16)13.91 (9.85-19.29)49.77 (43.02-56.53)
Impaired fasting glycaemia2.03 (0.80-5.06)12.03 (7.97-17.76)9.71 (6.78-13.73)
Impaired glucose tolerance5.53 (2.91-10.27)10.91 (7.19-16.22)6.16 (3.72-10.04)
Hyperlipidemia< 0.0001
No42.98 (35.28-51.03)18.26 (13.59-24.08)6.47 (3.95-10.44)
Yes57.02 (48.97-64.72)81.74 (75.92-86.41)93.53 (89.56-96.05)
Atherosclerotic cardiovascular disease0.0001
No91.71 (86.19-95.14)85.37 (79.93-89.52)73.59 (66.71-79.48)
Yes8.29 (4.86-13.81)14.63 (10.48-20.07)26.41 (20.52-33.29)
Congestive heart failure0.0361
No97.68 (91.30-99.41)92.50 (88.18-95.32)89.97 (85.65-93.09)
Yes2.32 (0.59-8.70)7.50 (4.68-11.82)10.03 (6.91-14.35)
Myocardial infarction0.0001
No96.82 (93.77-98.40)92.55 (88.00-95.47)86.79 (81.91-90.51)
Yes3.18 (1.60-6.23)7.45 (4.53-12.00)13.21 (9.49-18.09)
Angina pectoris0.0004
No98.25 (95.92-99.26)95.83 (92.84-97.60)90.84 (86.86-93.71)
Yes1.75 (0.74-4.08)4.17 (2.40-7.16)9.16 (6.29-13.14)
Sleep duration (hours) 6.20 (5.90-6.49)6.40 (6.20-6.59)6.61 (6.40-6.82)0.0904


Write to the Help Desk